Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF: insights from the STEP-HFpEF programme
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
9 More presentations in this session
Professor S. von Haehling (Goettingen, DE)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
You may be interested in
Congress Presentation
Congress Presentation
Congress Session
